Thursday, August 6, 2026

New Cold War Rising: The Death of Reunification and the Birth of a Hostile State

Kim Jong Un labels South Korea as hostile, promoting a 'cold peace' strategy while avoiding direct provocations in diplomacy.

Kim Jong Un Oversees ‘Nuclear Trigger’ Drill in Latest Show of Force

Kim Jong Un oversaw a missile exercise to enhance North Korea's nuclear readiness, emphasizing the need for rapid response to threats.

ROMEO AND JULIET FROM HELL: The Twisted Internet Obsession With A Trump-Kim Wedding To End The Nuclear Crisis!

A viral meme suggests Barron Trump marry Kim Ju-ae for world peace, sparking mixed reactions on social media amid global tensions.

Tag: EMA

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.